march 19th tirzepatide 🚨 Important Update on Compounded 🚨, As of 19th, the FDA has officially banned compounded Tirzepatide formulations. We believe this is a huge disservice to patients seeking affordable March 10, 2025: Patients transitioning

However, the peptide may support post-surgical healing and potentially accelerate rehabilitation timelines

Serious adverse events occurred in 4% of the retatrutide placebo groups.

While on adjuvant chemo and hormonal therapy, her weight increased dramatically and peaked 4 years later

A recent BMJ Practice Pointer reminded me that a simple, structured approach can help differentiate common benign oral lesions from those requiring urgent referral

Research shows that tirzepatide, the active ingredient in Zepbound, can reduce body weight by up to 21%, whereas semaglutide, the active ingredient in Ozempic, reduces body weight by up to 11%although results may vary based on individual experiences and dose